These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29500545)

  • 21. Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes.
    Schiller GJ; Slack J; Hainsworth JD; Mason J; Saleh M; Rizzieri D; Douer D; List AF
    J Clin Oncol; 2006 Jun; 24(16):2456-64. PubMed ID: 16651647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study.
    Scott BL; Ramakrishnan A; Fosdal M; Storer B; Becker P; Petersdorf S; Deeg HJ
    Br J Haematol; 2010 Jun; 149(5):706-10. PubMed ID: 20331464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxiredoxin 2 expression is increased in neutrophils of patients with refractory cytopenia with multilineage dysplasia.
    Kazama H; Teramura M; Kurihara S; Yoshinaga K; Kato T; Motoji T
    Br J Haematol; 2014 Sep; 166(5):720-8. PubMed ID: 24862795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
    Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
    Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematologic outcomes of myelodysplastic syndromes treatment with hypomethylating agents in community practice.
    Bordoni RE; Feinberg BA; Gilmore JW; Haislip S; Jackson JH; Farrelly E; Kim E; Buchner D
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):350-4. PubMed ID: 21816373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cyclosporine A in combination with thalidomide for the treatment of patients with myelodysplastic syndromes].
    Xu ZF; Qin TJ; Zhang Y; Liu KQ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jul; 31(7):451-5. PubMed ID: 21122398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Response to Traditional Chinese Herbs Containing Realgar (As
    Zhou QB; Du Y; Zhang SS; Liu ZT; Ma R; Xu YG
    Cancer Manag Res; 2021; 13():55-63. PubMed ID: 33442294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration in endoglin-related angiogenesis in refractory cytopenia with multilineage dysplasia.
    del Rey M; Pericacho M; Velasco S; Lumbreras E; López-Novoa JM; Hernández-Rivas JM; Rodríguez-Barbero A
    PLoS One; 2013; 8(1):e53624. PubMed ID: 23341958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes.
    Hlaváčková A; Štikarová J; Pimková K; Chrastinová L; Májek P; Kotlín R; Čermák J; Suttnar J; Dyr JE
    Free Radic Biol Med; 2017 Jul; 108():1-7. PubMed ID: 28300669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic trioxide in patients with myelodysplastic syndromes: a phase II multicenter study.
    Vey N; Bosly A; Guerci A; Feremans W; Dombret H; Dreyfus F; Bowen D; Burnett A; Dennis M; Ribrag V; Casadevall N; Legros L; Fenaux P
    J Clin Oncol; 2006 Jun; 24(16):2465-71. PubMed ID: 16651646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
    Raza A; Mehdi M; Mumtaz M; Ali F; Lascher S; Galili N
    Cancer; 2008 Oct; 113(7):1596-604. PubMed ID: 18720364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application of bioinformatics analysis to optimize amifostine combination therapeutic regimen of myelodysplastic syndrome].
    Lu XC; Yang B; Zhu HL; Fan H; Li SX; Liu Y; Yao SQ
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(26):1834-7. PubMed ID: 19953928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membranous glomerulonephritis in a patient with myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia.
    Ko KI; Lee MJ; Doh FM; Koo HM; Kim CH; Shin DH; Oh HJ; Han SH; Kang SW; Choi KH; Yoo TH
    Kidney Res Clin Pract; 2013 Sep; 32(3):134-7. PubMed ID: 26877929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome.
    Raza A; Galili N; Smith SE; Godwin J; Boccia RV; Myint H; Mahadevan D; Mulford D; Rarick M; Brown GL; Schaar D; Faderl S; Komrokji RS; List AF; Sekeres M
    Cancer; 2012 Apr; 118(8):2138-47. PubMed ID: 21887679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.
    Bacher U; Kern W; Alpermann T; Schnittger S; Haferlach C; Haferlach T
    Leuk Res; 2012 Jul; 36(7):826-31. PubMed ID: 22554895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
    Raptis A; Duh MS; Wang ST; Dial E; Fanourgiakis I; Fortner B; Paley C; Mody-Patel N; Corral M; Scott J
    Transfusion; 2010 Jan; 50(1):190-9. PubMed ID: 19719471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical features of cytopenia with bone marrow hypoplasia in children: an analysis of 100 cases].
    Yang WY; Chen XJ; Zhang PH; Hama A; Ito M; Kojima S; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):448-52. PubMed ID: 23791060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
    Xia JY; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.